Healthcare professionals are patients’ and parents’ most-trusted source of information about COVID-19 vaccines.
We encourage healthcare professionals of all practices to talk with their patients about the vaccines, to listen to their concerns and answer questions by providing factual information. Whether you have these discussions with your patients during an in-person office visit, through e-mail messages on your patient portal, or during consultation in your pharmacy, your strong COVID-19 vaccine recommendation matters. DHEC provides posters, flyers, and signage available in different sizes, fact sheets and other materials, in English and Spanish, online here for helping promote the safety and effectiveness of COVID-19 vaccines in all healthcare facilities.
Additional links and resources
- NEW: Evusheld Antibody Treatment for COVID-19 High-risk Groups (DHEC information; Dec. 21, 2021)
- NEW: DHEC Supports CDC Recommendation to Use Pfizer and Moderna COVID-19 Vaccines Over Janssen (Dec. 17, 2021)
- NEW: Fact Sheet for Healthcare Providers: Emergency Use Authorization for Evusheld™ (Dec. 9, 2021)
- Everyone Ages 18 and Older Should Get a Booster Shot (Updated Nov. 29, 2021)
- Third Dose of COVID-19 Vaccine for Immunocompromised People (Aug.13, 2021)
- Project Firstline - CDC’s new infection control training collaborative
- COVID-19 vaccine hesitancy: 10 tips for talking with patients
- Benefits of Getting Vaccinated
- COVID-19 Vaccine Conversation Starters
- Reporting Requirements for COVID-19 Vaccine Providers
- Moderna COVID-19 Vaccine - Storage & Handling
- Moderna COVID-19 Vaccine - What to Expect During & After Your Injection
- COVID-19 Case Guidance
- COVID-19 Contact Guidance
- COVID-19 Vaccination Provider Guidance & Enrollment
- Reporting of COVID-19 Positive and Negative Laboratory Results
- CDC Clinical Care Guidance for Healthcare Professionals about Coronavirus (COVID-19) (Oct. 9, 2020)
- CLIA Certification and COVID-19 Testing Memo
- Pharmacy Guide: Remdesivir for Injection (100 mg) Lyophilized Powder
- Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of Remdesivir (GS-5734™)
- FDA MedWatch Consumer Voluntary Reporting (Form FDA 3500B)
- CDC Information for Laboratories on COVID-19
